entertainment -WSS

entertainment

author：entertainment 2025-09-29 19:59:57 - browse：64

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Suspects arrested after 3 women attacked on Manhattan's West Side: Police

WSS

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

It's time to take a new tack for treating Alzheimer's

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Crinetics acromegaly drug succeeds in late

Covid hospitalizations on the rise, Humana says

explore

entertainment

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Florida babysitter arrested over hot car death, authorities say

23andMe had bad news about my health. I wish a person had delivered it

Amazon on where the company's health care bets are headed next

Virginia high school admissions case could be legal follow

Pfizer's RSV vaccine recommended for approval in Europe

Malaria cases in Florida and Texas: Here’s what you need to know

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Hepatitis C has a cure — but many Americans still lack access to it

ALS advocates say criticism of new drugs misses bigger picture

entertainment

'Make People Better': The CRISPR babies story you probably don't know

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Florida babysitter arrested over hot car death, authorities say

Medicaid rebukes states for mistakenly disenrolling children

'The View' co

knowledge

knowledge

focus

hotspot